CLINICAL_TRIALS
trial_result
· 2012-02-16
Clinical Trial Update: S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma [Phase 2]
Summary
Phase 2 trial evaluating hydroxyurea for unresectable benign meningioma was completed and results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SWOG Cancer Research Network | Conditions: Adult Meningioma | Phase 2 | Status: COMPLETED | Results posted: 2012-02-16